Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 5/20 | 0.73 |
| ▸ | GRM5 | P41594 | 1/20 | 0.72 |
| ▸ | CLPP | Q16740 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 3/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4143017 | 1.00 | HSD11B1 (0.73) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL4144201 | 0.89 | HSD11B1 (0.85) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL4144196 | 0.89 | HSD11B1 (0.85) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL4145392 | 0.86 | HSD11B1 (0.72) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL4145397 | 0.86 | HSD11B1 (0.72) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL4148633 | 0.85 | GRM5 (0.69) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL4148638 | 0.85 | GRM5 (0.69) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL193123 | 0.85 | GRM5 (0.90) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL4133752 | 0.84 | HSD11B1 (0.75) | HSD11B1GRM5CLPPMEN1KMT2A | |
| SCHEMBL4133747 | 0.84 | HSD11B1 (0.75) | HSD11B1GRM5CLPPMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090197897-A1 | Novel Oxadiazole Derivatives and Their Use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors | ADDEX PHARMA SA (CH) | 2009-08-06 | — | — | US | disclosed |
| US-20090197897-A1 | Novel Oxadiazole Derivatives and Their Use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors | ADDEX PHARMA SA (CH) | 2009-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197897-A1 | Novel Oxadiazole Derivatives and Their Use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors | GRM5, GRM2, GRM3 | HSD11B1 3098/4885GRM5 1/4885CLPP 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.